Blog
EGFR Pathway and YAP in Non-Small Cell Lung Cancer
Understanding the EGFR Pathway and YAP in Non-Small Cell Lung CancerThe epidermal growth factor receptor (EGFR) pathway plays a pivotal role in the development and progression of non-small cell lung cancer (NSCLC). This article delves into the intricate relationship between the EGFR pathway, Yes-associated protein (YAP), and the tumor microenvironment, highlighting their implications for cancer progression and treatment strategies.IntroductionNon-small cell lung cancer (NSCLC) is one of the most prevalent forms of lung cancer, characterized by its aggressive nature and poor prognosis. The EGFR pathway is a well-established oncogenic pathway that significantly influences tumor growth and meta
…
22nd Jul 2025